FDA approves AstraZeneca's Baxfendy, first-in-class drug for tough-to-treat hypertension
The FDA cleared baxdrostat, a first-in-class aldosterone synthase inhibitor, offering a new option for adults whose blood pressure resists standard therapies.
Health & Science
Sponsoredaixipi
Create AI images with your own API key
aixipi runs on desktop/web, uses your own model API balance, and avoids subscription lock-in.
Try aixipi →